SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-064911
Filing Date
2012-11-26
Accepted
2012-11-26 17:13:39
Documents
3
Period of Report
2012-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v328937_8k.htm 8-K 14723
2 EXHIBIT 5.1 v328937_ex5-1.htm EX-5.1 5519
3 EXHIBIT 10.20 v328937_ex10-20.htm EX-10.20 15486
  Complete submission text file 0001144204-12-064911.txt   36896
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 121224945
SIC: 2836 Biological Products, (No Diagnostic Substances)